Metformin for aging and cancer prevention
- PMID: 21084729
- PMCID: PMC3006019
- DOI: 10.18632/aging.100230
Metformin for aging and cancer prevention
Abstract
Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors in aging. Insulin/insulin-like growth factor 1 (IGF-1) signaling molecules that have been linked to longevity include daf-2 and InR and their homologues in mammals, and inactivation of the corresponding genes increases life span in nematodes, fruit flies and mice. It is possible that the life-prolonging effect of caloric restriction is due to decreasing IGF-1 levels. Evidence has emerged that antidiabetic drugs are promising candidates for both life span extension and prevention of cancer. Thus, antidiabetic drugs postpone spontaneous carcinogenesis in mice and rats, as well as chemical and radiation carcinogenesis in mice, rats and hamsters. Furthermore metformin seems to decrease cancer risk in diabetic patients.
Conflict of interest statement
The author declares no conflict of interests.
References
-
- Anisimov VN. Vol 2. Boca Raton, FL: CRC Press; 1987. Carcinogenesis and Aging.
-
- Anisimov VN. Premature ageing prevention: Limitations and perspectives of pharmacological interventions. Current Drugs Targets. 2006;7:1485–1503. - PubMed
-
- Spindler SR. Caloric restriction: From soup to nuts. Ageing Res Rev. 2010;9:324–353. - PubMed
-
- Anisimov VN. Carcinogenesis and aging 20 years after: escaping horizon. Mech Ageing Dev. 2009;130:105–121. - PubMed
-
- Weindruch R, Walford R. Springfield, Ill.: C.C. Thomas; 1988. The Retardation of Aging and Disease by Dietary Restriction.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
